Best practice portal main page

Tratamientos farmacológicos para los trastornos de la personalidad y del consumo de sustancias

Summary of the evidence

Rating: 
  • Efectividad desconocida

Un examen exhaustivo (EMCDDA 2015) encontró que:

  • no existe evidencia de que cualquier farmacoterapia sea particularmente beneficiosa en la comorbilidad de los trastornos de la personalidad con trastornos del consumo de sustancias

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option
  • Tratamiento de comorbilidad integrado
Desired outcome(s)
  • mejorar los resultados en salud mental
  • reducir el consumo de sustancias
Area(s)
  • Tratamiento
Specific substance or pattern of use
  • comorbilidad
Target group(s) or setting(s)
  • pacientes con diagnóstico dual

References

Explore all resources in the Best practice portal

 

Miniguides

A one-stop-shop for anyone planning or delivering health and social responses.

 

Implementation

Implementation inventories including Xchange, Healthy Nightlife Toolbox, EUPC and EIB

 

Evidence

All of the latest research and evidence on drug-related interventions.

 

Standards

Standards and guidelines for drug-related interventions, aimed at improving their quality.

Collaborations and partnerships in best practice

Logo of the Cochrane Collaboration
Logo of the Campbell Collaboration
Grade logo
WHO logo

About the Best practice portal

Top